Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases
Status:
Recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects and best dose of ropidoxuridine when given
together with whole brain radiation therapy in treating patients with cancer that has spread
to the brain (brain metastases). Ropidoxuridine may help whole brain radiation therapy work
better by making cancer cells more sensitive to the radiation therapy.